TNFSF14 and neoplasm: In a subcutaneous mouse model of breast cancer, Dai et al. found that LIGHT caused tumor cell death, enhanced T lymphocyte invasion, and triggered systemic antitumor immune function, making it a promising drug for cancer immunotherapy [56].